Valuation: EUROAPI

Market Cap 70.6M 79.13M 65.77M 59.85M 113M 7.62B 114M 795M 309M 3.89B 297M 291M 12.5B P/E 2026 *
-0.56x
P/E 2027 * -1.31x
Enterprise Value 126M 141M 117M 107M 201M 13.58B 202M 1.42B 551M 6.93B 530M 518M 22.29B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.23x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day-12.68%
1 week-12.68%
Current month-12.68%
1 month-27.81%
3 months-44.07%
6 months-45.51%
Current year-67.89%
1 week 0.84
Extreme 0.8446
0.84
1 month 0.84
Extreme 0.8446
0.97
Current year 0.84
Extreme 0.8446
2.54
1 year 0.84
Extreme 0.8446
3.59
3 years 0.84
Extreme 0.8446
10.85
5 years 0.84
Extreme 0.8446
23.4
10 years 0.84
Extreme 0.8446
23.4
Manager TitleAgeSince
Chief Executive Officer - 08/12/2024
Director of Finance/CFO - 16/10/2024
Compliance Officer - 26/11/2023
Director TitleAgeSince
Director/Board Member 62 05/05/2022
Director/Board Member - 05/05/2022
Chairman 57 08/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-12.68%-12.68% - - 79.45M
+0.02%-3.52%+35.27%+111.11% 1,019B
-1.21%-6.99%+34.42%+60.96% 617B
+1.16%-0.16%+15.50%+80.31% 464B
-3.28%-6.14%+57.16%+34.71% 356B
+0.93%-1.83%+20.98%+41.43% 333B
+0.12%-4.05%+10.09%+33.53% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-3.62%+37.01%+52.02% 218B
-0.08%-4.98%+27.34%+93.61% 179B
Average -1.82%-3.54%+25.64%+57.30% 410.8B
Weighted average by Cap. -0.43%-3.54%+28.58%+68.51%

Financials

2026 *2027 *
Net sales 748M 839M 697M 634M 1.19B 80.78B 1.2B 8.42B 3.28B 41.23B 3.15B 3.08B 133B 748M 838M 696M 634M 1.19B 80.7B 1.2B 8.42B 3.27B 41.19B 3.15B 3.08B 132B
Net income -125M -140M -116M -106M -199M -13.44B -200M -1.4B -545M -6.86B -524M -513M -22.05B -53.63M -60.12M -49.96M -45.47M -85.63M -5.79B -86.26M -604M -235M -2.95B -226M -221M -9.5B
Net Debt 55.24M 61.92M 51.46M 46.83M 88.19M 5.96B 88.84M 622M 242M 3.04B 232M 227M 9.78B 105M 118M 97.67M 88.88M 167M 11.32B 169M 1.18B 459M 5.78B 441M 432M 18.57B
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.7390EUR
Average target price
1.000EUR
Spread / Average Target
+35.32%

Quarterly revenue - Rate of surprise